Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

In a world where weight management is increasingly prioritized, appetite suppressants have gained immense popularity for ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.